Pharmaceuticals, Biotechnology and Life Sciences
Proceeds used to develop small molecule inhibitor of SARS-CoV-2 and other RNA viruses NAARDEN, The Netherlands & MUNICH–(BUSINESS WIRE)–Forbion, a…
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing…
STRASBOURG, France–(BUSINESS WIRE)–#BT001–Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment…
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing…
Statistically significant protective effect at a frequency located beyond the electrode array at 8 months post implantation Statistically significant electrode…
Statistically significant protective effect at a frequency located beyond the electrode array at 8 months post implantation Statistically significant electrode…
Statistically significant protective effect at a frequency located beyond the electrode array at 8 months post implantation Statistically significant electrode…
STRASBOURG, France–(BUSINESS WIRE)–#BT001–Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment…
STRASBOURG, France–(BUSINESS WIRE)–#BT001–Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment…
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing…